Device Radiology

Embocath Plus Microcatheter

Payments companies reported to CMS as associated with Embocath Plus Microcatheter. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2,138associated payments (2023-2025)
20clinicians with associated payments
1company reporting

By year

2023 $1,005
2025 $1,133

Payments reported as associated with Embocath Plus Microcatheter, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $1,066
Interventional Cardiology $612
Advanced Heart Failure and Transplant Cardiology $192
Cardiovascular Disease $103
Family Medicine $71.21
Diagnostic Radiology $66.56

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Embocath Plus Microcatheter

These are the largest totals companies reported as associated with Embocath Plus Microcatheter. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Peter Hathaway Farmington, UT Vascular & Interventional Radiology $791.22
David Roberts Sacramento, CA Interventional Cardiology $191.53
Sailesh Shah Sacramento, CA Interventional Cardiology $191.51
Gurpreet Sodhi Sacramento, CA Advanced Heart Failure and Transplant Cardiology $191.51
Kent Wong Modesto, CA Cardiovascular Disease $75.61
Sulman Razzaq Modesto, CA Interventional Cardiology $75.60
John Prologo Atlanta, GA Vascular & Interventional Radiology $71.22
Mahmood Razavi Orange, CA Vascular & Interventional Radiology $71.21
Maria Constante Portland, OR Family Medicine $71.21
Abraham Levitin Cleveland, OH Diagnostic Radiology $66.56

Prescribed Embocath Plus Microcatheter?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.